ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

CLN Celsion Corp

0.00
0.00 (0.00%)
Pre Market
Last Updated: -
Delayed by 15 minutes
Share Name Share Symbol Market Type
Celsion Corp AMEX:CLN AMEX Ordinary Share
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.00 -

Clariant confirms SABIC to complete purchase of 24.99% stake in Clariant after receiving all regulatory approvals

10/09/2018 6:00am

GlobeNewswire


Clariant AG / Clariant confirms SABIC to complete purchase of 24.99% stake in Clariant after receiving all regulatory approvals . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement.

  • All regulatory approvals received for SABIC's 24.99% stake in Clariant
  • Unconditional closing of purchase to take place in the next days
  • After closing, SABIC becomes Clariant's largest strategic anchor shareholder
 
 

Muttenz, September 10, 2018 - Clariant, a world leader in specialty chemicals, today announced that SABIC has received the final outstanding regulatory approvals from the competition authorities for the purchase of a 24.99% stake in Clariant. Therefore, an unconditional closing of the purchase will take place in the next days which makes SABIC Clariant's largest strategic anchor shareholder, and second anchor shareholder beside the group of former shareholders of Süd-Chemie.

SABIC, the world's third largest diversified chemical company and a long-standing partner of Clariant in the Catalyst joint venture Scientific Design, entered into a purchase agreement regarding the acquisition of the stake in Clariant in January 2018.

"With SABIC receiving all the regulatory approvals and the transaction set to be completed, we look forward to further developing the strategic relationship between both companies in order to generate value for all stakeholders", said Hariolf Kottmann, CEO of Clariant.

Clariant and SABIC are discussing about possible future collaborations that will generate value for the stakeholders of both companies. Any outcome of these discussions will be presented in due course.

Corporate Media Relations Investor Relations
 

Jochen Dubiel

Phone +41 61 469 63 63
jochen.dubiel@clariant.com
Anja Pomrehn

Phone +41 61 469 63 73
anja.pomrehn@clariant.com
Claudia Kamensky

Phone +41 61 469 63 63
claudia.kamensky@clariant.com
Maria Ivek

Phone +41 61 469 63 73
maria.ivek@clariant.com
Thijs Bouwens

Phone +41 61 469 63 63
Thijs.bouwens@clariant.com

 
 
Follow us on Twitter, Facebook, Google Plus, LinkedIn.  
www.clariant.com

 

 

Clariant is a globally leading specialty chemicals company, based in Muttenz near Basel/Switzerland. On 31 December 2017 the company employed a total workforce of 18 135. In the financial year 2017, Clariant recorded sales of CHF 6.377 billion for its continuing businesses. The company reports in four business areas: Care Chemicals, Catalysis, Natural Resources, and Plastics & Coatings. Clariant's corporate strategy is based on five pillars: focus on innovation through R&D, add value with sustainability, reposition portfolio, intensify growth, and increase profitability.

Press release english
Press release german



This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Clariant AG via Globenewswire

--- End of Message ---

Clariant AG
Rothausstrasse 61 Muttenz 1 Switzerland

ISIN: CH0012142631;


1 Year Celsion Chart

1 Year Celsion Chart

1 Month Celsion Chart

1 Month Celsion Chart